Compare Abbott Laboratories (ABT) vs Southwest Airlines Co (LUV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Southwest Airlines Co — how do they compare? Abbott Laboratories trades at $95.42 (market cap $166.94B), while Southwest Airlines Co trades at $48.47 (market cap $24.16B). The key difference: Abbott Laboratories is far larger — about 6.9× Southwest Airlines Co's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | LUV | |
|---|---|---|
Market Cap | $166.94B | $24.16B |
Sector | Health | Industrials |
52-Week High | $136.62 | $54.80 |
52-Week Low | $82.57 | $29.06 |
Enterprise Value | $193.69B | $27.23B |
Dividend Yield | 2.63% | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Southwest Airlines (LUV) trades at $49.43, down 1.63% today, with a bullish technical signal from moving averages. The company reported revenue of $28.06B in 2025, with a net income margin of 2.83%, and has beaten earnings estimates in two of the last three quarters. Recent news highlights sector optimism due to lower fuel costs and strong travel demand, with analyst consensus leaning toward a buy rating and a $52.47 price target.
The outlook for LUV is cautiously optimistic, supported by earnings growth potential and favorable industry trends, but risks include volatile fuel prices and competitive pressures. The stock presents a moderate opportunity for investors seeking exposure to the airline sector, with upside to the consensus target but sensitivity to macroeconomic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
